Erste Group Downgrades CME Group (CME) to Hold
Erste Group analyst Hans Engel downgraded CME Group (NASDAQ: CME) from Buy to Hold.
The analyst comments "The company did not provide any guidance for 2026 when it published its 1Q results. Despite the recent record figures, there are some risks and negative aspects. CME Group's revenues are only sustainable in an environment of uncertainty accompanied by high financial market volatility. With stabilisation and geopolitical uncertainties subside, trading volumes and transaction fees may fall again. We expect the positive revenue momentum to date to weaken over the course of the year. The stock should continue its relative weakness compared to the sector index for the time being."
For an analyst ratings summary and ratings history on CME Group click here. For more ratings news on CME Group click here.
Shares of CME Group closed at $256.06 yesterday.